Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy

OBJECTIVE: To evaluate the frequency of JC polyomavirus (JCPyV) infection and anti-JCPyV antibodies in patients with multiple sclerosis under natalizumab therapy. METHODS: Presence of anti-JCPyV antibodies and JCPyV DNA was analyzed in 39 patients with relapsing-remitting multiple sclerosis undergoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Clausi, Valeria, Giannecchini, Simone, Magnani, Eliana, Repice, Anna, Mechi, Claudia, Martelli, Francesco, Azzi, Alberta, Massacesi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299884/
https://www.ncbi.nlm.nih.gov/pubmed/25610882
http://dx.doi.org/10.1212/NXI.0000000000000058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299884/
https://www.ncbi.nlm.nih.gov/pubmed/25610882
http://dx.doi.org/10.1212/NXI.0000000000000058

Ejemplares similares